Related references
Note: Only part of the references are listed.Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Rapid Up-Regulation and Granule-Independent Transport of Perforin to the Immunological Synapse Define a Novel Mechanism of Antigen-Specific CD8+ T Cell Cytotoxic Activity
George Makedonas et al.
JOURNAL OF IMMUNOLOGY (2009)
Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus
Dominick J. Laddy et al.
JOURNAL OF VIROLOGY (2009)
Influenza vaccine market dynamics
Hedwig Kresse et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children
Bruce D. Forrest et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
Dominick J. Laddy et al.
PLOS ONE (2008)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge
CC Breathnach et al.
VACCINE (2006)
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature
SL Epstein
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus
RD Wesley et al.
VACCINE (2004)
Share Paper
